BIOANALYTICAL SYSTEMS INC·4

Sep 18, 9:50 PM ET

KISSINGER PETER 4

4 · BIOANALYTICAL SYSTEMS INC · Filed Sep 18, 2018

Insider Transaction Report

Form 4
Period: 2018-09-14
Transactions
  • Purchase

    Common Stock

    2018-09-14$1.74/sh+10,000$17,3821,033,457 total
Holdings
  • Common Stock

    848,220
Footnotes (4)
  • [F1]Represents the purchase of 10,000 shares in multiple transactions ranging in price from $1.68 to $1.78 per share, resulting in a weighted average purchase price of $1.7382. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.
  • [F2]Shares were purchased by Peter T. Kissinger individually; direct holdings of Peter T. Kissinger after this transaction include 595,910 shares held jointly with Candice B. Kissinger. Shares that are reported as individually held by Candice B. Kissinger or held jointly by Candice B. Kissinger and her children are deemed to be indirectly held by Peter T. Kissinger.
  • [F3]The total amount of shares beneficially owned by Peter T. Kissinger reflects the sale of 200 shares held by Peter T. Kissinger individually on March 7, 2008, which was inadvertently omitted from the Form 4 filed by Peter T. Kissinger on March 10, 2008.
  • [F4]Shares held directly by Candice B. Kissinger; includes 595,910 shares held jointly by Peter T. Kissinger and Candice B. Kissinger and 1,354 shares held jointly by Candice B. Kissinger and her children. Shares that are reported as individually held by Peter T. Kissinger are deemed to be indirectly held by Candice B. Kissinger.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT